Sinopharm CNBG COVID-19 vaccine

Sinopharm CNBG COVID-19 vaccine
Vaccine description
Target	SARS-CoV-2
Vaccine type	Protein subunit
Clinical data
Routes of; administration	Intramuscular
Legal status
Legal status	Full list of Sinopharm CNBG authorizations;

Sinopharm CNBG COVID-19 vaccine is a COVID-19 vaccine developed by China National Biotec Group (CNBG), a subsidiary of Sinopharm.[1][2]

They claim to be the world's first "second generation" protein recombination vaccine.[3]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.